Showing 41 - 50 of 916
Anutin wants Covid reclassified to let govt avoid paying for treatment
Apinya Wipatayotin, Published on 01/06/2022
» Ending the government's burden of paying for Covid-19 treatment is more important than declaring the disease endemic, so the health minister is proposing to reclassify it as a "disease under surveillance".
Will mask-wearing remain a fixture?
Life, Kanokporn Chanasongkram, Published on 30/05/2022
» As the Ministry of Public Health plans to ease more Covid-19 measures in June, are we ready to take the masks off?
Pfizer Covid vaccine for under-fives effective with three doses
AFP, Published on 23/05/2022
» WASHINGTON: The Pfizer/BioNTech Covid vaccine is safe and effective for children aged six months to under five years when given in three doses, the companies said in a statement Monday.
First lot of local Covid vaccine produced
Online Reporters, Published on 07/05/2022
» The first batch of ChulaCov19, the first messenger-RNA vaccine developed in Thailand, has been produced and is awaiting Food and Drug Administration (FDA) approval for the first two phases of human trials, a government spokesperson said on Saturday.
Omicron as severe as previous Covid variants, large study finds
Published on 05/05/2022
» The Omicron variant of the SARS-CoV2 virus is intrinsically as severe as previous variants, unlike assumptions made in previous studies that it was more transmissible but less severe, a large study in the United States has found.
Covid lessons for cholera handling
Oped, Published on 04/05/2022
» Since Covid-19 engulfed the world two years ago, "unprecedented" has become something of a buzzword. But while the coronavirus has posed unique challenges at a time of deep global interconnectedness, pandemics are nothing new. The Covid-19 pandemic is not even the only one we are currently experiencing. In much of the developing world, cholera outbreaks are proliferating.
Moderna seeks US authorisation for Covid-19 vaccine in children under 6: statement
AFP, Published on 28/04/2022
» WASHINGTON: US biotech firm Moderna said Thursday it had submitted a request for an emergency use authorisation in the United States for its Covid-19 vaccine for children aged six months to under six years.
The quest for a coronavirus supervaccine
AFP, Published on 25/04/2022
» PARIS: As vaccine makers rush to stamp out new Covid-19 variants, some scientists have set their sights higher, aiming for a universal coronavirus vaccine that could tackle any future strains and possibly even stave off another pandemic.
Chinese battle web censors to vent lockdown anger
Published on 23/04/2022
» Chinese internet users have rallied to outwit government censors on a video documenting weeks of lockdown in Shanghai, flooding social media feeds as frustration continued to escalate over strict Covid Zero rules.
Biotech breakthrough in virus vaccines
Life, Thana Boonlert, Published on 12/04/2022
» The National Centre for Genetic Engineering and Biotechnology (Biotec) recently announced the success of developing a pseudotyped virus for a Covid-19 vaccine and drug trials.